Resting-State Functional Network Organization Is Stable Across Adolescent Development for Typical and Psychosis Spectrum Youth.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
26 02 2020
Historique:
pubmed: 20 8 2019
medline: 9 2 2021
entrez: 20 8 2019
Statut: ppublish

Résumé

Resting-state functional neuroimaging captures large-scale network organization; whether this organization is intact or disrupted during adolescent development across the psychosis spectrum is unresolved. We investigated the integrity of network organization in psychosis spectrum youth and those with first episode psychosis (FEP) from late childhood through adulthood. We analyzed data from Philadelphia Neurodevelopmental Cohort (PNC; typically developing = 450, psychosis spectrum = 273, 8-22 years), a longitudinal cohort of typically developing youth (LUNA; N = 208, 1-3 visits, 10-25 years), and a sample of FEP (N = 39) and matched controls (N = 34). We extracted individual time series and calculated correlations from brain regions and averaged them for 4 age groups: late childhood, early adolescence, late adolescence, adulthood. Using multiple analytic approaches, we assessed network stability across 4 age groups, compared stability between controls and psychosis spectrum youth, and compared group-level network organization of FEP to controls. We explored whether variability in cognition or clinical symptomatology was related to network organization. Network organization was stable across the 4 age groups in the PNC and LUNA typically developing youth and PNC psychosis spectrum youth. Psychosis spectrum and typically developing youth had similar functional network organization during all age ranges. Network organization was intact in PNC youth who met full criteria for psychosis and in FEP. Variability in cognitive functioning or clinical symptomatology was not related to network organization in psychosis spectrum youth or FEP. These findings provide rigorous evidence supporting intact functional network organization in psychosis risk and psychosis from late childhood through adulthood.

Sections du résumé

BACKGROUND
Resting-state functional neuroimaging captures large-scale network organization; whether this organization is intact or disrupted during adolescent development across the psychosis spectrum is unresolved. We investigated the integrity of network organization in psychosis spectrum youth and those with first episode psychosis (FEP) from late childhood through adulthood.
METHODS
We analyzed data from Philadelphia Neurodevelopmental Cohort (PNC; typically developing = 450, psychosis spectrum = 273, 8-22 years), a longitudinal cohort of typically developing youth (LUNA; N = 208, 1-3 visits, 10-25 years), and a sample of FEP (N = 39) and matched controls (N = 34). We extracted individual time series and calculated correlations from brain regions and averaged them for 4 age groups: late childhood, early adolescence, late adolescence, adulthood. Using multiple analytic approaches, we assessed network stability across 4 age groups, compared stability between controls and psychosis spectrum youth, and compared group-level network organization of FEP to controls. We explored whether variability in cognition or clinical symptomatology was related to network organization.
RESULTS
Network organization was stable across the 4 age groups in the PNC and LUNA typically developing youth and PNC psychosis spectrum youth. Psychosis spectrum and typically developing youth had similar functional network organization during all age ranges. Network organization was intact in PNC youth who met full criteria for psychosis and in FEP. Variability in cognitive functioning or clinical symptomatology was not related to network organization in psychosis spectrum youth or FEP.
DISCUSSION
These findings provide rigorous evidence supporting intact functional network organization in psychosis risk and psychosis from late childhood through adulthood.

Identifiants

pubmed: 31424081
pii: 5551294
doi: 10.1093/schbul/sbz053
pmc: PMC7442350
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-407

Subventions

Organisme : NIMH NIH HHS
ID : R37 MH057881
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH057881
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH080243
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH084053
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH103204
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Neuropsychopharmacology. 2011 Sep;36(10):2009-17
pubmed: 21654735
J Nerv Ment Dis. 1992 Nov;180(11):723-8
pubmed: 1431824
Cereb Cortex. 2014 Dec;24(12):3116-30
pubmed: 23825317
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13848-53
pubmed: 16945915
Cereb Cortex. 2013 Oct;23(10):2380-93
pubmed: 22875861
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
Brain Struct Funct. 2015 Mar;220(2):1173-86
pubmed: 24469153
Neuroimage. 2015 Aug 15;117:67-79
pubmed: 25987368
J Neurosci. 2010 Jul 14;30(28):9477-87
pubmed: 20631176
Front Hum Neurosci. 2016 Mar 30;10:132
pubmed: 27064387
Brain Connect. 2014 Sep;4(7):547-57
pubmed: 24999746
Neuroimage. 2014 Feb 1;86:544-53
pubmed: 23921101
Neuroimage. 2014 May 15;92:356-68
pubmed: 24384150
Neuron. 2015 Aug 5;87(3):657-70
pubmed: 26212711
Schizophr Res. 2011 Aug;130(1-3):86-93
pubmed: 21458238
Neuroimage Clin. 2015 Nov 18;10:96-106
pubmed: 26793435
Schizophr Res. 2009 Mar;108(1-3):85-92
pubmed: 19138834
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Neuroimage. 2010 May 1;50(4):1690-701
pubmed: 20079856
Neuroimage. 2009 Feb 1;44(3):893-905
pubmed: 18976716
Netw Neurosci. 2018 Jun 01;2(2):175-199
pubmed: 30215032
Neuroimage. 2017 Jul 1;154:174-187
pubmed: 28302591
Arch Gen Psychiatry. 2008 Jan;65(1):28-37
pubmed: 18180426
Schizophr Res. 2008 Dec;106(2-3):356-62
pubmed: 18809299
Neuroimage. 2017 Aug 15;157:695-704
pubmed: 28456583
Medicine (Baltimore). 2017 Mar;96(13):e6223
pubmed: 28353559
J Neurosci. 2013 Nov 13;33(46):18109-24
pubmed: 24227721
Neuroimage. 2013 Nov 15;82:208-25
pubmed: 23747457
Schizophr Bull. 2009 May;35(3):509-27
pubmed: 19155345
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13681-6
pubmed: 26483477
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20015-20
pubmed: 21041625
Psychiatry Res. 2010 Jul 30;183(1):59-68
pubmed: 20553873
Hum Brain Mapp. 2009 Feb;30(2):403-16
pubmed: 18072237
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8577-82
pubmed: 16723398
Netw Neurosci. 2018 Oct 01;3(1):1-26
pubmed: 30793071
Hum Brain Mapp. 2009 Nov;30(11):3795-811
pubmed: 19434601
J Neurosci. 2017 Jul 26;37(30):7263-7277
pubmed: 28634305
Curr Opin Neurobiol. 2015 Feb;30:85-91
pubmed: 25464373
Am J Psychiatry. 2012 Oct;169(10):1092-9
pubmed: 23032387
PLoS One. 2014 May 01;9(5):e94423
pubmed: 24788455
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13040-5
pubmed: 19620724
Am J Psychiatry. 2019 Mar 1;176(3):196-207
pubmed: 30654642
Neuroimage. 2008 Jul 1;41(3):835-48
pubmed: 18434199
Schizophr Res. 2016 Oct;176(2-3):83-94
pubmed: 27450778
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15531-6
pubmed: 17878310
Nat Neurosci. 2016 Dec;19(12):1718-1726
pubmed: 27723746
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Schizophr Res. 2012 Aug;139(1-3):13-8
pubmed: 22633527
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
Neuroimage. 2014 Jan 1;84:320-41
pubmed: 23994314
Schizophr Res. 2006 Oct;87(1-3):60-6
pubmed: 16875801
Nat Commun. 2015 Dec 09;6:8885
pubmed: 26648521
Neuron. 2018 Apr 18;98(2):439-452.e5
pubmed: 29673485
Cereb Cortex. 2016 Jan;26(1):288-303
pubmed: 25316338
Sci Rep. 2016 Aug 26;6:32328
pubmed: 27561736
Neuron. 2016 Oct 19;92(2):544-554
pubmed: 27693256
PLoS Biol. 2015 Dec 29;13(12):e1002328
pubmed: 26713863
Neuron. 2014 Sep 17;83(6):1335-53
pubmed: 25233316
Hum Brain Mapp. 2013 Sep;34(9):2154-77
pubmed: 22438275
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 5;369(1653):
pubmed: 25180304
World Psychiatry. 2014 Oct;13(3):296-305
pubmed: 25273303
Biol Psychiatry. 2011 Jul 1;70(1):64-72
pubmed: 21514570
Neuroimage. 2012 Jan 16;59(2):1404-12
pubmed: 21888983
J Child Psychol Psychiatry. 2015 Dec;56(12):1356-1369
pubmed: 25858255
PLoS Comput Biol. 2009 May;5(5):e1000381
pubmed: 19412534
Mol Psychiatry. 2018 Nov 8;:
pubmed: 30410064
Biol Psychiatry. 2013 Mar 15;73(6):565-73
pubmed: 22980587
Neuroimage. 2016 Jan 1;124(Pt B):1115-1119
pubmed: 25840117
JAMA Psychiatry. 2015 May;72(5):456-65
pubmed: 25785510
Neuroimage. 2012 Jul 16;61(4):1471-83
pubmed: 22446491
JAMA Psychiatry. 2016 May 1;73(5):515-24
pubmed: 26982085
Biol Psychiatry. 2015 Jan 15;77(2):147-57
pubmed: 25034946
JAMA Psychiatry. 2014 Feb;71(2):109-18
pubmed: 24306091
Annu Rev Neurosci. 2015 Jul 8;38:151-70
pubmed: 26154978
Schizophr Bull. 2003;29(2):325-40
pubmed: 14552507
Cereb Cortex. 2011 Jan;21(1):145-54
pubmed: 20421249
Mol Psychiatry. 2015 Dec;20(12):1508-15
pubmed: 26033240
Biol Psychiatry. 2017 Oct 1;82(7):511-521
pubmed: 28274468
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Dialogues Clin Neurosci. 2018 Jun;20(2):101-111
pubmed: 30250387
JAMA Psychiatry. 2015 Aug;72(8):743-4
pubmed: 26061674
Psychiatry Res. 2015 Aug 30;233(2):148-57
pubmed: 26123450
Annu Rev Psychol. 2001;52:83-110
pubmed: 11148300
Brain. 2008 Apr;131(Pt 4):945-61
pubmed: 18299296
Aust N Z J Psychiatry. 2018 Sep;52(9):864-875
pubmed: 29806483
Nature. 2016 Aug 11;536(7615):171-178
pubmed: 27437579
Clin Perinatol. 1990 Mar;17(1):83-102
pubmed: 2318019
Early Hum Dev. 2016 Jul;98:29-35
pubmed: 27351350
Neuroimage. 2013 Nov 15;82:403-15
pubmed: 23747961
Child Dev. 2011 Sep-Oct;82(5):1357-71
pubmed: 21824131
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Neurosci Biobehav Rev. 2011 Apr;35(5):1110-24
pubmed: 21115039
JAMA Psychiatry. 2015 Sep;72(9):882-91
pubmed: 26267151
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):927-932
pubmed: 29339482
Nat Neurosci. 2016 Aug 26;19(9):1175-87
pubmed: 27571196

Auteurs

Maria Jalbrzikowski (M)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Fuchen Liu (F)

Department of Statistics, Carnegie Mellon University, Pittsburgh, PA.

William Foran (W)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Kathryn Roeder (K)

Department of Statistics, Carnegie Mellon University, Pittsburgh, PA.
Department of Computational Biology, Carnegie Mellon University, Pittsburgh, PA.

Bernie Devlin (B)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.
Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA.

Beatriz Luna (B)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.
Department of Psychology, University of Pittsburgh, Pittsburgh, PA.
Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH